Loïc Ysebaert
Institut universitaire du cancer de Toulouse Oncopole(FR)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Advanced Breast Cancer Therapies, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions(2014)308 cited
- → Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib(2018)291 cited
- → Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation(2014)225 cited
- → Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma(2017)215 cited
- → Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study(2016)125 cited
- → Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers(2018)118 cited
- → Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors(2020)117 cited
- → A revised international prognostic score system for Waldenström’s macroglobulinemia(2019)104 cited
- → Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia(2010)84 cited
- → BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib(2023)63 cited